Effect of adrenergic blockade on plasma adrenomedullin concentration during static handgrip in patients with heart failure

Clinical Physiology and Functional Imaging

Volumn 26, Issue 6, 2006, Pages 328-334

  Krzeminski K ^a   Nazar, K ^a   Cybulski, G ^a   Mikulski, T ^a  

^a MOSSAKOWSKI MEDICAL RESEARCH CENTRE   (Poland)

Author keywords

Adrenomedullin; Carvedilol; Catecholamines; Haemodynamics; Heart failure; Static handgrip

Indexed keywords

ADRENALIN; ADRENOMEDULLIN; CARVEDILOL; CATECHOLAMINE; NORADRENALIN;

ADRENERGIC RECEPTOR BLOCKING; ADRENERGIC SYSTEM; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DIASTOLIC BLOOD PRESSURE; DISEASE CLASSIFICATION; HAND GRIP; HEART FAILURE; HEART HEMODYNAMICS; HEART RATE; HEART STROKE VOLUME; HUMAN; MALE; MUSCLE CONTRACTION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN SECRETION; STATIC EXERCISE; VASCULAR RESISTANCE; VOLUNTARY MOVEMENT;

ADRENERGIC BETA-ANTAGONISTS; ADRENOMEDULLIN; AGED; ANALYSIS OF VARIANCE; BIOLOGICAL MARKERS; BLOOD PRESSURE; CARBAZOLES; CARDIAC OUTPUT; CHRONIC DISEASE; CORONARY ARTERIOSCLEROSIS; CORONARY ARTERY DISEASE; EPINEPHRINE; EXERCISE TEST; HEART FAILURE; HEART FAILURE, CONGESTIVE; HEART RATE; HUMANS; LINEAR MODELS; MALE; MIDDLE AGED; NOREPINEPHRINE; PROPANOLAMINES; SYMPATHETIC NERVOUS SYSTEM; TREATMENT OUTCOME; VASCULAR RESISTANCE;

EID: 33750137506     PISSN: 14750961     EISSN: 1475097X     Source Type: Journal    
DOI: 10.1111/j.1475-097X.2006.00693.x     Document Type: Article

References (40)

1. Azevedo ER, Kubo T, Mak S, Al-Hesayen A, Schofield A, Allan R, Kelly S, Newton GE, Floras JS, Parker JD. Nonselective versus selective beta-adrenergic receptor blockade in congestive heart failure: differential effects on sympathetic activity. Circulation (2001); 104: 2194-2199.
2. Beltowski J, Jamroz A. Adrenomedullin-what do we know 10years since its discovery ? Pol J Pharmacol (2004); 56: 5-27.
3. Cheung BM, Li CY, Wong LY. Adrenomedullin: Its role in the cardiovascular system. Semin Vasc Med (2004); 4: 129-134.
4. Cybulski G. Computer method for automatic determination of stroke volume using impedance cardiography signals. Acta Physiol Pol (1988); 39: 494-503.
5. Cybulski G, Miśkiewicz Z, Szulc J, Torbicki A, Pasierski T. A comparison between the automatized impedance cardiography and pulsed-wave Doppler echocardiography methods for measurements of stroke volume (SV) and systolic time intervals (STI). J Physiol Pharmacol (1993); 44: 251-258.
6. Cybulski G, Ksiazkiewicz A, Łukasik W, Niewiadomski W, Pałko T. Central hemodynamics and ECG ambulatory monitoring device with signals recording on PCMCIA memory cards. Medical and Biological Engineering and Computing (1996); 34: 79-80.
7. DaPrada M, Zurcher G. Radioenzimatic assay of plasma and urinary catecholamines in man and various animal species. Physiological and pharmacological applications. In: Radioimmunoassay of Drugs and Hormones in Cardiovascular Medicine (eds Albertini A, DaPrada M, Pescar A) (1979) Elsevier North Holland Biomedical Press, Amsterdam, pp. 112-119.
8. De Matos LD, Gardenghi G, Rondon MU, Soufen HN, Tirone AP, Barretto AC, Brum PC, Middlekauff HR, Negrao CE. Impact of 6months of therapy with carvedilol on muscle sympathetic nerve activity in heart failure patients. J Card Fail (2004); 10: 496-502.
9. Esler M, Kaye D, Lambert G, Esler D, Jennings G. Adrenergic nervous system in heart failure. Am J Cardiol (1997); 80: 7L-14L.
10. Eto T, Kitamura K, Kato J. Biological and clinical roles of adrenomedullin in circulation control and cardiovascular diseases. Clin Exp Pharmacol Physiol (1999); 26: 371-380.
11. Eto T, Kato J, Kitamura K. Regulation of production and secretion of adrenomedullin in the cardiovascular system. Regul Pept (2003); 112: 61-69.
12. Gasiorowska A, Nazar K, Mikulski T,. Hemodynamic and neuroendocrine predictors of lower body negative pressure (LBNP) intolerance in healthy young men. J Physiol Pharmacol (2005); 56: 179-193.
13. Herman RB, Jesudason PJ, Mustafa AM, Husain R, Choy AM, Lang CC. Differential effects of carvedilol and atenolol on plasma noradrenaline during exercise in humans. Br J Clin Pharmacol (2003); 55: 134-138.
14. Hryniewicz K, Androne AS, Hudaihed A, Katz SD. Comparative effects of carvedilol and metoprolol on regional vascular responses to adrenergic stimuli in normal subjects and patients with chronic heart failure. Circulation (2003); 108: 971-976.
15. Ishimitsu T, Nishikimi T, Salto Y, Kitamura K, Eto T, Kangawa K, Matsuo H, Omae T, Matsuoka H. Plasma levels of adrenomedullin, a newly identified hypotensive peptide in patients with hypertension and renal failure. J Clin Invest (1994a); 94: 2158-2161.
16. Ishimitsu T, Kojima M, Kangawa K, Hino J, Matsuoka H, Kitamura K, Eto T, Matsuo H. Genomic structure of human adrenomedullin gene. Biochem Biophys Res Commun (1994b); 203: 631-639.
17. Ishizaka Y, Tanaka M, Kitamura K, Kangawa K, Minamino N, Matsuo H, Eto T. Adrenomedullin stimulates cyclic AMP formation in rat vascular smooth muscle cells. Biochem Biophys Res Commun (1994); 200: 642-646.
18. Jougasuki M, Rodeheffer RJ, Redfield MM, Yamamoto K, Chi-Ming W, Mc Kinley LJ. Cardiac secretion of adrenomedullin in human heart failure. J Clin Invest (1996); 97: 2370-2376.
19. Kato J, Kobayashi K, Etoh T, Tanaka M, Kitamura K, Imamura T, Koiwaya Y, Kangawa K, Eto T. Plasma adrenomedullin concentration in patients with heart failure. J Clin Endocrinol Metab (1996); 81: 180-183.
20. Krzemiński K, Kruk B, Wojcik-Ziolkowska E, Kozera J, Cybulski G, Nazar K. Effect of static handgrip on plasma adrenomedullin concentration in patients with heart failure and in healthy subjects. J Physiol Pharmacol (2002); 53: 199-210.
21. Krzemiński K, Mikulski T, Kruk B, Nazar K. Plasma adrenomedullin response to maximal exercise in healthy subjects. J Physiol Pharmacol (2003); 54: 225-232.
22. Kubo T, Azevedo ER, Newton GE, Parker JD, Floras JS. Lack of evidence for peripheral alpha(1)-adrenoceptor blockade during long-term treatment of heart failure with carvedilol. J Am Coll Cardiol (2001); 38: 1463-1469.
23. Malfatto G, Facchini M, Branzi G, Riva B, Sala L, Perego GB. Long-term treatment with the beta-blocker carvedilol restores autonomic tone and responsiveness in patients with moderate heart failure. J Cardiovasc Pharmacol (2003); 42: 125-131.
24. Morimoto A, Nishikimi T, Takaki H, Okano Y, Matsuoka H, Takishita S, Kitamura K, Miyata A, Kangawa K, Matsuo H. Effect of exercise on plasma adrenomedullin and natriuretic peptide levels in myocardial infarction. Clin Exp Pharmacol Physiol (1997); 24: 315-320.
25. Nakamura M, Yoshida H, Makita S, Arakawa N, Niinuma H, Hiramori K. Potent and long-lasting vasodilatory effects of adrenomedullin in humans. Circulation (1997); 95: 1214-1221.
26. Nazar K, Jezova D, Kowalik-Borówka E. Plasma vasopressin, growth hormone and ACTH responses to static handgrip in healthy subjects. Eur J Appl Physiol (1989); 58: 400-404.
27. Nicholls MG. Hemodynamic and hormonal actions of adrenomedullin. Braz J Med Biol Res (2004); 37: 1247-1253.
28. Nicholls MG, Charles CJ, Lainchbury JG, Lewis LK, Rademaker MT, Richards AM, Yandle TG. Adrenomedullin in heart failure. Hypertens Res (2003); 26: S135-S140.
29. Nishikimi T, Saito Y, Kitamura K, Ishimitsu T, Eto T, Kangawa K, Matsuo H, Omae T, Matsuoka H. Increased plasma levels of adrenomedullin in patients with heart failure. JACC (1995); 26: 1424-1431.
30. Nishikimi T, Yoshihara F, Mori Y, Kangawa K, Matsuoka H. Cardioprotective effect of adrenomedullin in heart failure. Hypertens Res (2003); 26: S121-S127.
31. Nishikimi T, Asakawa H, Iida H, Matsushita Y, Shibasaki I Tadokoro K, Mori Y, Mori H, Mochizuki Y, Okamura Y, Miyoshi S, Kangawa K, Matsuoka H. Different secretion patterns of two molecular forms of cardiac adrenomedullin in pressure- and volume-overloaded human heart failure. J Card Fail (2004); 10: 321-327.
32. Parkes DG, May CN. Direct cardiac and vascular actions of adrenomedullin in conscious sheep. Br J Pharmacol (1997); 120: 1179-1185.
33. Piquard F, Charloux A, Mettauer B, Epailly E, Lonsdorfer E, Popescu S, Lonsdorfer J, Geny B. Exercise-induced increase in circulating adrenomedullin is related to mean blood pressure in heart transplant recipients. J Clin Endocrinol Metab (2000); 85: 2828-2831.
34. Poveda JJ, Bernazueta JR, Ochoteco A, Montalban C, Garcia-Unzzueta MT, Fernandez C, Pena N, Amado JA. Age-related responses of vasoactive factors during acute exercise. Horm Metab Res (1998); 30: 668-672.
35. Rademaker MT, Cameron VA, Charles CJ, Lainchbury JG, Nicholls MG, Richards AM. Adrenomedullin and heart failure. Regul Pept (2003); 112: 51-60.
36. Rössler A, Laszlo Z, Haditsch B, Hinghofer-Szalkay HG. Orthostatic stimuli rapidly change plasma adrenomedullin in humans. Hypertension (1999); 34: 1147-1151.
37. Szokodi I, Kinnunen P, Ruskoaho H. Inotropic effect of adrenomedullin in the isolated perfused rat heart. Acta Physiol Scand (1996); 156: 151-152.
38. Szokodi I, Kinnunen P, Tavi P, Weckstrom M, Toth M, Ruskoaho H. Evidence for cAMP-independent mechanisms mediating the effects of adrenomedullin, a new inotropic peptide. Circulation (1998); 97: 1062-1070.
39. Tanaka M, Kitamura K, Ishizaka Y, Ishiyama Y, Kato J, Kangawa K, Eto T. Plasma adrenomedullin in various diseases and exercise-induced changes in adrenomedullin in healthy subjects. Internal Med (1995); 34: 728-733.
40. White CM. Catecholamines and their blockade in congestive heart failure. Am J Health Syst Pharm (1998); 55: 676-682.